Financial News
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
By:
Vor Biopharma via
GlobeNewswire
August 01, 2023 at 08:00 AM EDT
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.
Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

More News
View More
3 Healthcare Pathbreakers With Long-Term Tailwinds
September 01, 2025
Via MarketBeat
3 Tariff-Proof Retailers Making New All-time Highs
September 01, 2025
With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report
September 01, 2025
Via MarketBeat
3 Gold ETFs That Could Surge If the Fed Cuts Rates This Month
September 01, 2025
Time to Take Profits on Strategy Stock? 3 Reasons You Should
September 01, 2025
Via MarketBeat
Tickers
MSTR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.